WRBY - Warby Parker Inc.


26.95
-1.840   -6.827%

Share volume: 3,095,100
Last Updated: 05-12-2026
Medical Equipment/Ophthalmic Goods: 0.01%

PREVIOUS CLOSE
CHG
CHG%

$28.79
-1.84
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
37%
Profitability 38%
Dept financing 41%
Liquidity 35%
Performance 35%
Company vs Stock growth
vs
Performance
5 Days
-8.80%
1 Month
26.64%
3 Months
19.99%
6 Months
55.96%
1 Year
45.83%
2 Year
73.87%
Key data
Stock price
$26.95
P/E Ratio 
2,549.38
DAY RANGE
$26.67 - $28.66
EPS 
$0.05
52 WEEK RANGE
$14.96 - $31.00
52 WEEK CHANGE
$54.18
MARKET CAP 
2.580 B
YIELD 
N/A
SHARES OUTSTANDING 
122.715 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,992,630
AVERAGE 30 VOLUME 
$2,688,674
Company detail
CEO: Neil Blumenthal
Region: US
Website: warbyparker.com
Employees: 3,030
IPO year: 2021
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses. As of March 17, 2022, it had 160 retail stores in the United States and Canada.

Recent news